Nomax, INC FDA Inspection Record

FEI 1937310 · Inspections, Form 483s, warning letters and import refusals

Nomax, INC is an FDA-registered facility (FEI 1937310) located in Affton, MO, US. Registered operations: MANUFACTURE. RegDataLab tracks 10 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Feb 25, 2026: No Action Indicated (NAI)
Inspections on record
10 (1 OAI, 5 VAI, 4 NAI)
Last OAI inspection
Oct 27, 2016
Warning letters
1 listed by FDA for this FEI, latest Dec 15, 2016
Recalls as the recalling firm
3, latest Apr 19, 2024

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 25, 2026No Action Indicated (NAI)No citations listed
Feb 16, 2024No Action Indicated (NAI)No citations listed
Dec 2, 2022Voluntary Action Indicated (VAI)No citations listed
Jun 24, 2022No Action Indicated (NAI)No citations listed
Feb 1, 2018Voluntary Action Indicated (VAI)No citations listed
Oct 27, 2016Official Action Indicated (OAI)DHR - not or inadequately maintained (21 CFR 820.184)
Documentation (21 CFR 820.80(e))
Nonconforming product control (21 CFR 820.90(a))
Investigation of device failures (21 CFR 820.198(c))
and 3 more
Sep 17, 2014Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Acceptable supplier records, inadequate records (21 CFR 820.50(a)(3))
Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a))
and 14 more
Jan 31, 2012Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Absence of Written Procedures (21 CFR 211.100(a))
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Establishment of calibration procedures (21 CFR 211.160(b)(4))
and 5 more
Mar 25, 2011Voluntary Action Indicated (VAI)GMP Training Frequency (21 CFR 211.25(a))
Written program not followed (21 CFR 211.166(a))
Jul 26, 2010No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Apr 19, 2024Class IID-0462-2024GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100… and 3 more products
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to…
Apr 13, 2021Class IIID-0387-2021Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100…
Subpotent Drug
Mar 24, 2015Class IIID-0961-2015Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluorescein… and 2 more products
Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of…

FDA record score

15 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

8 records behind this number
RecordDatePoints x age weightAdds
Warning letter on FDA's dashboard, which does not show close-outsDec 15, 201630 x 0.257.5
Inspection classified VAIDec 2, 20226 x 0.63.6
Class II recall D-0462-2024, this FEI as the recalling firmApr 19, 20244 x 0.62.4
Inspection classified VAIFeb 1, 20186 x 0.251.5
Inspection classified OAIOct 27, 201610 years or older, so it adds no points0
Inspection classified VAISep 17, 201410 years or older, so it adds no points0
Inspection classified VAIJan 31, 201210 years or older, so it adds no points0
Inspection classified VAIMar 25, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Nomax, INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Nomax, INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Nomax, Inc.
Location
Affton, MO (US)
Registration Expires
Dec 31, 2026
Operations
MANUFACTURE
Source
both

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.